National Research Corporation (NASDAQ:NRC – Get Free Report) declared a quarterly dividend on Wednesday, April 15th. Stockholders of record on Friday, June 26th will be given a dividend of 0.16 per share on Friday, July 10th. This represents a c) annualized dividend and a dividend yield of 3.2%. The ex-dividend date is Friday, June 26th.
National Research has raised its dividend payment by an average of 0.2%annually over the last three years.
National Research Stock Performance
Shares of NRC opened at $20.04 on Wednesday. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. National Research has a one year low of $11.01 and a one year high of $22.79. The firm has a market capitalization of $455.91 million, a P/E ratio of 51.38 and a beta of 0.37. The business has a fifty day moving average of $18.56 and a 200 day moving average of $17.71.
Analyst Upgrades and Downgrades
NRC has been the subject of a number of recent research reports. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Citizens Jmp began coverage on shares of National Research in a report on Monday. They issued a “market outperform” rating and a $23.00 price objective on the stock. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, National Research currently has an average rating of “Moderate Buy” and an average target price of $23.00.
View Our Latest Report on National Research
National Research Company Profile
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.
Further Reading
- Five stocks we like better than National Research
- Chevron’s Microsoft Deal Turns Natural Gas Into an AI Trade
- Why nVent Could Be a Long-Term AI Infrastructure Winner
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
